BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 11230633)

  • 1. Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas.
    Namimoto T; Yamashita Y; Mitsuzaki K; Nakayama Y; Makita O; Kadota M; Takahashi M
    Radiology; 2001 Mar; 218(3):642-6. PubMed ID: 11230633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging.
    Tsushima Y; Ishizaka H; Matsumoto M
    Radiology; 1993 Mar; 186(3):705-9. PubMed ID: 8430178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors.
    Bilbey JH; McLoughlin RF; Kurkjian PS; Wilkins GE; Chan NH; Schmidt N; Singer J
    AJR Am J Roentgenol; 1995 Mar; 164(3):637-42. PubMed ID: 7863885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience.
    Schindera ST; Soher BJ; Delong DM; Dale BM; Merkle EM
    Radiology; 2008 Jul; 248(1):140-7. PubMed ID: 18566172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of adrenal lesions using chemical shift MRI: comparison between 1.5 Tesla and two echo time pair selection at 3.0 Tesla MRI.
    Nakamura S; Namimoto T; Morita K; Utsunomiya D; Oda S; Nakaura T; Hirai T; Yamashita Y
    J Magn Reson Imaging; 2012 Jan; 35(1):95-102. PubMed ID: 22002867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of chemical shift subtraction MRI in characterization of adrenal masses.
    Savci G; Yazici Z; Sahin N; Akgöz S; Tuncel E
    AJR Am J Roentgenol; 2006 Jan; 186(1):130-5. PubMed ID: 16357391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
    Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
    Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
    Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
    Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures.
    Mayo-Smith WW; Lee MJ; McNicholas MM; Hahn PF; Boland GW; Saini S
    AJR Am J Roentgenol; 1995 Jul; 165(1):91-5. PubMed ID: 7785642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation.
    Fujiyoshi F; Nakajo M; Fukukura Y; Tsuchimochi S
    AJR Am J Roentgenol; 2003 Jun; 180(6):1649-57. PubMed ID: 12760936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging.
    Korobkin M; Lombardi TJ; Aisen AM; Francis IR; Quint LE; Dunnick NR; Londy F; Shapiro B; Gross MD; Thompson NW
    Radiology; 1995 Nov; 197(2):411-8. PubMed ID: 7480685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging of the adrenal gland.
    Boland GW; Lee MJ
    Crit Rev Diagn Imaging; 1995; 36(2):115-74. PubMed ID: 7612177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal masses in patients with malignancy: prospective comparison of echo-planar, fast spin-echo, and chemical shift MR imaging.
    Schwartz LH; Panicek DM; Koutcher JA; Brown KT; Getrajdman GI; Heelan RT; Burt M
    Radiology; 1995 Nov; 197(2):421-5. PubMed ID: 7480686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal masses: characterization with T1-weighted MR imaging.
    Chezmar JL; Robbins SM; Nelson RC; Steinberg HV; Torres WE; Bernardino ME
    Radiology; 1988 Feb; 166(2):357-9. PubMed ID: 3336711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distinction between adrenal adenomas and metastases using 0.5 Telsa MR imaging: diagnosis with out-of-phase T2*-weighted gradient-field-echo image].
    Ichikawa T; Fujimoto H; Uchiyama G; Murakami K; Ohtomo K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):229-34. PubMed ID: 8177696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Magnetic resonance in the study of suprarenal neoplasms. Qualitative and quantitative analysis of signal intensity].
    Maurea S; Caracò C; Castelli L; Filice S; Alfano B; Ruffolo F; Ziviello M; Salvatore M
    Radiol Med; 1998 Mar; 95(3):199-207. PubMed ID: 9638166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of adrenal masses with MR imaging: comparison of techniques.
    Reinig JW; Stutley JE; Leonhardt CM; Spicer KM; Margolis M; Caldwell CB
    Radiology; 1994 Jul; 192(1):41-6. PubMed ID: 8208962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR evaluation of adrenal masses at 1.5 T.
    Baker ME; Blinder R; Spritzer C; Leight GS; Herfkens RJ; Dunnick NR
    AJR Am J Roentgenol; 1989 Aug; 153(2):307-12. PubMed ID: 2750617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of adrenal adenomas and metastases: correlation between unenhanced computed tomography and chemical shift magnetic resonance imaging.
    Rescinito G; Zandrino F; Cittadini G; Santacroce E; Giasotto V; Neumaier CE
    Acta Radiol; 2006 Feb; 47(1):71-6. PubMed ID: 16498936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?
    Haider MA; Ghai S; Jhaveri K; Lockwood G
    Radiology; 2004 Jun; 231(3):711-6. PubMed ID: 15118113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.